Status: Recruiting
GEKO Venous Thromboembolism Prevention Study
This multicentre, randomised geko™ venous thromboembolism (VTE) prevention study will prospectively collect clinical data on VTE occurrences in immobile patients after stroke, who will be randomised, on a 1:1 allocation, to receive either standard of care (Intermittent Pneumatic Compression) or geko™ neuromuscular electrostimulation device. The aim is to assess the prevention of VTE during a follow-up period of 90 days (three months) post-randomisation.
Participants needed: 1,200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Firstkind LtdUpdated: Mar 4, 2025Locations: 18
Eligibility criteria
Age 18 years or older [+3]
Inability to gain consent from the patient, or a declaration from a Personal Con... [+13]